Continuing SSRI Treatment During Pregnancy Associated with Mild, Temporary Newborn Effects, Not Major Complications

A new study published in JAMA Network Open suggests that continuing selective serotonin reuptake inhibitors (SSRIs) during pregnancy is primarily associated with mild, temporary newborn effects, such as slightly lower Apgar scores and higher odds of meconium-stained amniotic fluid, rather than serious adverse outcomes. The research, which analyzed electronic health record data from over 1,000 pregnancies, aims to support shared decision-making for pregnant patients on SSRIs.

Context

Selective serotonin reuptake inhibitors are commonly prescribed for depression and anxiety. Previous concerns about the safety of these medications during pregnancy have led to uncertainty among patients and healthcare providers. This study, utilizing extensive electronic health record data, aims to clarify the risks associated with SSRI use in pregnant women.

Why it matters

This study provides critical insights for pregnant individuals who are considering or currently taking SSRIs. Understanding the potential effects on newborns can help in making informed choices about mental health treatment during pregnancy. It emphasizes the importance of balancing maternal mental health needs with fetal health considerations.

Implications

The findings suggest that while there are some mild effects on newborns, major complications are not prevalent, which may alleviate concerns for pregnant individuals. This could lead to increased adherence to SSRIs among those needing treatment for mental health conditions. It may also influence public health messaging regarding the safety of SSRIs in pregnancy.

What to watch

Healthcare providers may adjust their recommendations based on these findings, leading to more nuanced discussions about SSRI use during pregnancy. Expectant mothers currently on SSRIs might seek consultations to better understand the implications for their newborns. Future research may further explore long-term effects and additional factors influencing outcomes.